REGENERON PHARMACEUTICALS INC 4
4 · REGENERON PHARMACEUTICALS INC · Filed Jan 6, 2016
Insider Transaction Report
Form 4
BAKER CHARLES A
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2016-01-04+9,212→ 9,212 totalExercise: $520.01Exp: 2026-01-04→ Common Stock (9,212 underlying)
Footnotes (1)
- [F1]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.